EUVIMEDEUVIMED entdecken
Crossref

Optimising platelet usage during the induction therapy of acute myeloid leukaemia: Impact of physician education

John Gnanaraj, Abhishekh Basavarajegowda, Smita Kayal iD, Dibyajyothi Sahoo iD, Esha Toora, Biswajit Dubashi, Prasanth Ganesan iD

Transfusion Medicine · 2023-08 · 33 (4) · 290-296

DOI: 10.1111/tme.12967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion Medicine, online erschienen am 21.03.2023. Verfasst von John Gnanaraj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India. Hauptthemen laut MEDLINE: Blood Platelets, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Platelet products are scarce and expensive resources to be used judiciously. However, inappropriate usage is common. Lack of physician awareness is an important issue. We implemented a physician education program (PEP) along with repeated WhatsApp reminders at our centre. We audited the platelet usage practise before and after the intervention.

Methods

Charts of patients with acute myeloid leukaemia (AML) treated between January 2020 and August 2020 was reviewed, and the mean platelet usage per patient per day was calculated. Physician education was implemented between September 2020 and December 2020 (2 PowerPoint lectures of 20 min each and weekly WhatsApp messages containing the guidelines). Data of patients treated between Jan 2021 and August 2021 was prospectively audited to understand platelet usage and the indications for transfusions. The British Committee for the Standards in Haematology (BCSH) platelet transfusion guidelines were used as the adjudication tool to evaluate compliance. The mean platelet usage per day per kg body weight of a patient before and after the PEP was compared using the t ‐test.

Results

Group A (before physician education) consisted of 22 patients, and group B (after physician education) consisted of 23 patients. The mean number of platelet transfusions for each patient in a day per kg body weight was 125.7 × 10 8 in group A whereas, after the PEP, it had reduced to 73.9 × 10 8 amounting to an absolute reduction of 51 × 10 8 (58.8%) from the baseline with a statistical significance of P = 0.001. After implementing the PEP, the mean number of random donor platelets used reduced by 10.25 units (34% reduction), and the mean single donor platelets used reduced by 0.83 units (19% reduction). The 190 requests for platelet transfusion received during this period were classified as appropriate (157/190), which constituted 82.63% of the requests, or inappropriate (33/190), which accounted for 17.36%.

Conclusions

A short‐duration education programme supplemented with weekly WhatsApp messages and an active feedback mechanism on the rationale of platelet transfusion by the treating physician and transfusion specialist could significantly reduce platelet consumption during the therapy of acute myeloid leukaemia patients. This is a measure that can be considered by all high‐volume haematology centres, which can improve patient safety and reduce costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsLeukemia, Myeloid, AcuteHumansInduction ChemotherapyPlatelet Transfusion

Stichwörter der Autor:innen

acute myeloid leukaemiainduction chemotherapyphysician education programplatelet transfusion

Autor:innen und Institutionen

  • Department of Transfusion Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
  • Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.

ORCID-Profile: Smita Kayal, Dibyajyothi Sahoo, Prasanth Ganesan

Zitieren

APA

Gnanaraj, J., Basavarajegowda, A., Kayal, S., Sahoo, D., Toora, E., Dubashi, B., & Ganesan, P. (2023). Optimising platelet usage during the induction therapy of acute myeloid leukaemia: Impact of physician education. Transfusion Medicine, 33(4), 290-296. https://doi.org/10.1111/tme.12967

Vancouver

Gnanaraj J, Basavarajegowda A, Kayal S, Sahoo D, Toora E, Dubashi B, et al. Optimising platelet usage during the induction therapy of acute myeloid leukaemia: Impact of physician education. Transfusion Medicine. 2023;33(4):290-296. doi:10.1111/tme.12967

BibTeX
@article{Gnanaraj2023,
  author = {Gnanaraj, John and Basavarajegowda, Abhishekh and Kayal, Smita and Sahoo, Dibyajyothi and Toora, Esha and Dubashi, Biswajit and Ganesan, Prasanth},
  title = {Optimising platelet usage during the induction therapy of acute myeloid leukaemia: Impact of physician education},
  journal = {Transfusion Medicine},
  year = {2023},
  volume = {33},
  number = {4},
  pages = {290--296},
  doi = {10.1111/tme.12967}
}
Kostenlos starten →